MedPath

Clinical Impact of Automated Oxygen Administration on Confirmed or Suspected COVID-19 in the Emergency Department.

Conditions
Hyperoxia
Hypoxia
Hypoxemia
COVID-19
Registration Number
NCT05235386
Lead Sponsor
Laval University
Brief Summary

The aim of this study is to evaluate the impact of the FreeO2 system on the quality of the oxygen therapy in confirmed or suspected SARS-CoV-2 patients in the emergency department.

Detailed Description

The aim of this study is to evaluate the impact of the FreeO2 system on the quality of the oxygen therapy in confirmed or suspected SARS-CoV-2 patients in the emergency department. The quality of oxygen therapy is evaluated by the time spent in the SpO2 target (+/- 2% SpO2 target), time spent in hyperoxemia (\> 5% SpO2 target), time spent in hyperoxemia (\<5% SpO2 target).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Hypoxemic patients on automated oxygen therapy during their emergency department stay
  • Confirmed or suspected SARS-CoV-2 patients in the emergency department
Exclusion Criteria
  • Patient on automated oxygen therapy in the emergency department without accessible data of the FreeO2 device.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of time in the saturation target in patients on automated oxygen titration device.From the initiation of oxygen therapy with FreeO2 until the date of emergency department discharge or Stop of oxygen therapy with FreeO2 whichever came first, assessed up to 3 day after emergency admission

The percentage of time in target is defined by the percentage of time of (Target - 3% target) \< SpO2 value \< (Target + 3%) of the selected Spo2 target using automated oxygen titration device.

Secondary Outcome Measures
NameTimeMethod
Emergency length of stay.From emergency departement admission until the date of emergency department discharge assessed up to 3 day after emergency admission

Time of stay in hours in the emergency department.

Hospital length of stay.From emergency departement admission until the date of hospital discharge assessed up to 2 months after emergency admission

Time of stay in hours during hospitalisation Time of stay in hospitalisation setting (excluding the intensive care unit) and intensive care unit in days.

Oxygenation data - hyperoxemiaFrom the initiation of oxygen therapy with FreeO2 until the date of emergency department discharge or Stop of oxygen therapy with FreeO2 whichever came first, assessed up to 3 day after emergency admission

The percentage of time in hyperoxemia defined as a SpO2 value \> 5% from the target.

Oxygenation data - severe hypoxemiaFrom the initiation of oxygen therapy with FreeO2 until the date of emergency department discharge or Stop of oxygen therapy with FreeO2 whichever came first, assessed up to 3 day after emergency admission

The percentage of time in hypoxemia defined as a SpO2 value \< 85%

automated oxygen therapy durationFrom the initiation of oxygen therapy with FreeO2 until the date of emergency department discharge or Stop of oxygen therapy with FreeO2 whichever came first, assessed up to 3 day after emergency admission

Length of total time on automated oxygen therapy in the emergency department in hours.

Orientation of careFrom emergency departement admission until the date of hospital discharge assessed up to 2 months after emergency admission

Describe departement admission (emergency observation, general ward ,intensive care unit)

Oxygenation data - mild hypoxemiaFrom the initiation of oxygen therapy with FreeO2 until the date of emergency department discharge or Stop of oxygen therapy with FreeO2 whichever came first, assessed up to 3 day after emergency admission

The percentage of time in mild hypoxemia defined as a : (Target - 5% target) \< SpO2 value \< (Target - 2%)

Ventilatory supportFrom the initiation of oxygen therapy with FreeO2 until hospital discharge, assessed up to 2 months after emergency admission

Need of change in ventilatory support device : (mechanical ventilation, non-invasive mechanical ventilation, high flow nasal canula, oxygen therapy) during emergency length of stay

Trial Locations

Locations (1)

Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval

🇨🇦

Québec, Canada

© Copyright 2025. All Rights Reserved by MedPath